Constellation Brands posts Q2 beat but guidance and analyst price targets fall

Constellation Brands reported second‑quarter fiscal 2027 earnings of $3.74 per share on revenue of $2.63 billion, beating estimates. The company kept its FY27 EPS guidance of $11.20‑$11.90 and said organic net‑sales growth will be flat to slightly positive. Following the release, several analysts cut their price targets, citing margin pressure and a weaker second‑half outlook.

Goldman Sachs, RBC, HSBC, UBS and Piper Sandler all lowered their price targets for STZ, reducing the upside potential that investors had priced in. The cuts suggest that analysts expect lower earnings growth and tighter margins in the second half of FY27, which could weigh on the stock’s valuation.

  • 1Q2 earnings per share were $3.74, beating the $3.57 estimate cited by Morgan Stanley.
  • 2Revenue for the quarter was $2.63 billion, up 6% year‑over‑year.
  • 3Fiscal 2027 EPS guidance was set at $11.20‑$11.90.
  • 4Goldman Sachs cut its price target to $155 from $180.
  • 5RBC Capital reduced its price target to $182 from $185.
  • 6HSBC lowered its price target to $135 from $192.
  • SpikedAde acquisition cost is described as $75 million upfront with a total deal potential of $353 million in one source, while another source mentions only a $75 million spend; the total amount is unclear.

Sources